Compression stockings have flight-DVT evidence behind them, and no dental-tourism consent mentions them

Let me start where the skeptic is strongest, because compression stockings are easy to oversell and I am not going to oversell them. The randomised evidence for graduated compression stockings on flights establishes a narrower thing than the marketing around them implies. What the trials show is a reduction in asymptomatic deep vein thrombosis, clots detected on screening, mostly silent, in airline passengers on long flights [4]. What the trials do not show, because they are not large enough to show it, is that stockings prevent the rare symptomatic clot or the very rare fatal pulmonary embolism. General guidance reflects this honestly: stockings are not pushed on every traveller, and the baseline advice for a low-risk flyer is movement and hydration, not compression [1]. So if you came here expecting me to say everyone should wear them, I will not. For most flyers the absolute benefit is small.

But the patient this piece is about is not a low-risk flyer, and that changes the calculus entirely. The dental-tourism patient flying home after extensive oral surgery carries stacked thrombosis risk: recent surgery, a named independent risk factor, combined with a long-haul flight, a second independent risk factor. This is exactly the patient for whom a cheap, low-harm, evidence-backed measure has its strongest case. And here is the fact that should sit uncomfortably with anyone who defends the current dental-tourism consent process: that measure, with randomised trial evidence behind it, for a patient sitting precisely where the case is strongest, appears in no dental-tourism consent process at all. The stocking is missing because the risk conversation that would justify it is missing.

What the evidence actually says, stated honestly

I will hold myself to the same standard I hold clinics to, so let me state the evidence precisely rather than conveniently.

Graduated compression stockings apply more pressure at the ankle than higher up the leg, which assists venous return and counteracts the venous stasis that prolonged immobility produces [2]. Venous stasis from sitting still is one of the classic contributors to clot formation, and long-haul flying is a textbook stasis setting, which is the whole basis of the so-called economy class syndrome [4]. The mechanism is coherent: if stasis is part of the problem, a device that reduces stasis should reduce clots.

The trial evidence supports that mechanism within a defined boundary. Randomised controlled trials, the kind synthesised in Cochrane-style reviews, have shown that wearing graduated compression stockings on long flights reduces the incidence of asymptomatic DVT in passengers, the silent clots picked up on ultrasound screening [4]. That is a genuine, measured, randomised finding, and it is the strongest part of the case. The honest limits are two. First, the effect is demonstrated for asymptomatic clots; the trials are not powered to prove a reduction in the rare symptomatic or fatal events, so claiming stockings prevent death on a flight goes beyond the evidence. Second, stockings are not a substitute for the baseline measures, moving and hydrating, that apply to everyone [1]. I deal with the stacked-risk physiology itself in how DVT risk stacks when surgery meets a long-haul flight; this piece is about the one cheap intervention with evidence that the consent process ignores.

Why the post-surgical dental patient is the strong case

The reason general advice does not push stockings on everyone is that the absolute benefit in a low-risk traveller is small, and small absolute benefits do not justify universal use of anything. That logic is correct, and it is also exactly why it does not apply to the patient this piece is about.

The WHO travel-thrombosis work is explicit that the absolute risk of flight-associated VTE concentrates in travellers carrying additional risk factors: older age, obesity, a previous clot, an inherited clotting tendency, and recent surgery [1]. A patient flying home after extensive oral surgery has recent surgery, the named factor, by definition. If they are an older full-arch patient, they likely carry more of the list. Their absolute risk is not the baseline flyer’s small number; it is elevated by the stack. And the value of a low-harm intervention rises with absolute risk, because the same relative effect prevents more events when the underlying risk is higher. The patient for whom stockings are most worth discussing is precisely the post-surgical, long-haul, older patient, the modal serious dental-tourism case.

 WHO IS THE STOCKING CASE STRONGEST FOR?

 Traveller profile            Absolute VTE risk   Stocking case
 --------------------------   -----------------   -------------
 Healthy short-haul flyer        very low          weak
 Healthy long-haul flyer         low               modest
 Older long-haul flyer           higher            stronger
 Recent surgery + long-haul      stacked           STRONGEST
   (the dental-tourism patient
    flying home after oral
    surgery sits here)

 Evidence base: randomised trials show graduated compression
 stockings reduce ASYMPTOMATIC DVT on long flights. [4]
 They are cheap and, for most people, low-harm. [2]

 Appearance in dental-tourism consent: NONE.

 The intervention's case is strongest exactly where the
 consent process is silent.

The grid is the argument. Read down the rows and the case for stockings strengthens as risk stacks, peaking at the recent-surgery-plus-long-haul patient. Then read the bottom line: that is the patient dental tourism flies home, and the consent process says nothing.

Why nothing about stockings appears in consent

The absence is not, I think, a deliberate suppression of a known good measure. It is downstream of a deeper absence: the thrombosis risk itself is not in the consent conversation, so nothing addressing that risk can be either.

A measure can only appear in a consent process if the risk it mitigates has first been named. Domestic perioperative care names thrombosis risk routinely, which is why hospitals apply compression devices and prescribe prophylaxis as a matter of course after higher-risk surgery, the patient does not have to ask. The dental-tourism encounter is structured around the dental procedure and the schedule that sells it, not around perioperative thrombosis, so the risk is never named, and a mitigation for an unnamed risk has nowhere to live. The missing stocking is a symptom; the missing risk conversation is the disease. This is the same structural pattern I describe in the dental tourism trust gap: the process addresses the visible product, the implant, and omits the invisible perioperative risk, so the cheap, evidenced, low-harm measure that would address the invisible risk is omitted along with it.

There is a particular irony here. Dental tourism competes on price and convenience, and graduated compression stockings are about as cheap and convenient an intervention as medicine offers, a low-cost garment with randomised evidence behind it for exactly the patient profile being flown home [2] [4]. A process genuinely optimising for patient value at low cost would surface them. A process optimising for a frictionless sale leaves them out, because raising them means raising the thrombosis risk that the frictionless sale depends on not mentioning. The economics that should make stockings attractive are the same economics that keep them invisible.

The honest limits, so I do not become the thing I criticise

I would be doing exactly what I accuse clinics of if I sold stockings as a guarantee, so let me hold the limits firmly. Stockings reduce asymptomatic clots in trials; they are not proven to prevent the catastrophic event, and a patient who wears them is not thereby safe to ignore the rest of the picture [4]. They are not a substitute for assessing whether the trip should be split, for moving and hydrating on the flight, or for a proper perioperative risk assessment by someone qualified. They are also not literally consequence-free to apply blindly: fit and pressure grade matter, and there are circulatory conditions in which they are inappropriate [2], so the right move is a clinician considering them with you, not a panicked purchase at the airport.

And crucially, a stocking does not fix the structural problem. Even the perfect stocking on the perfect patient does not answer the question of who assessed the stacked risk, who owns a clot that presents after landing, or whether the itinerary was set by risk or by airfare. The stocking is a useful, evidenced, low-harm measure that belongs in a risk conversation. It is not a replacement for the conversation, and a clinic that handed out stockings while still skipping the thrombosis assessment would have addressed the symptom and left the disease. The intervention matters because its total absence is diagnostic of how little the underlying risk is being engaged with.

The questions that change the answer

A patient cannot run their own trial, but they can find out whether the evidenced measure was ever on the table.

1. Did anyone assess my stacked thrombosis risk and discuss low-harm measures like graduated compression stockings for the flight home? This is the diagnostic question. If the answer is no, it is not really the stocking that is missing, it is the entire perioperative thrombosis conversation, and the stocking is just the visible piece of that gap. If the answer is yes, you are dealing with a process that engaged the real risk.

2. Given my specific risk factors, is the case for stockings on my flight weak, modest, or strong? The honest answer depends on where you sit on the stack. An older patient flying long-haul after extensive surgery sits where the case is strongest, and a clinician who knows the evidence can tell you that. A clinician who waves the question away has not done the assessment.

3. What else, beyond stockings, does my stacked risk call for? Stockings are one low-harm measure, not the answer. The fuller answer might include splitting the journey, baseline movement and hydration, a seat that lets you move, covered in why a window seat is the wrong seat after oral surgery, and for the highest-risk full-arch case, the considerations in the All-on-4 and long-haul-flight DVT pairing. If the only measure discussed was nothing, the stocking question has done its job by exposing that.

The bottom line

Compression stockings are not a panacea, and I have held that concession throughout: the randomised evidence is for a reduction in asymptomatic flight DVT, not a proven shield against the rare fatal clot, and general advice rightly does not push them on every traveller [1] [4]. But the patient this piece is about is not the average traveller. The dental-tourism patient flying home after extensive oral surgery carries stacked risk, recent surgery plus a long-haul flight, and sits exactly where the case for a cheap, low-harm, evidence-backed measure is strongest [2]. That such a measure appears in no dental-tourism consent process is not really a fact about stockings. It is a fact about the thrombosis risk conversation that never happens, of which the missing stocking is merely the visible symptom. A process that genuinely optimised for low-cost patient value would surface an inexpensive evidenced garment for the high-risk patient it flies home. A process optimising for a frictionless sale omits it, because to raise the stocking is to raise the risk the sale depends on leaving unspoken. The defensible move for a patient is not to buy stockings on a guess, but to ask whether their stacked risk was assessed at all, and to treat the silence as the answer it is. For the wider framework, see our guide to going overseas for dental treatment, and for how we reason, our methodology.